FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387480006: Lidocaine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461658013 Lidocaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481571013 Lidocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492109015 Lignocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
56381000195118 lidocaina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
820781000172112 lidocaïne fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
71381000195111 Lidocain de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine (substance) Is a Class Ib antiarrhythmic agent (substance) true Inferred relationship Some
Lidocaine (substance) Is a Amide type local anesthetic false Inferred relationship Some
Lidocaine (substance) Is a Local anesthetic (substance) false Inferred relationship Some
Lidocaine (substance) Is a Amide and/or amide derivative (substance) false Inferred relationship Some
Lidocaine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sodium channel blocker true Inferred relationship Some
Lidocaine (substance) Is a Substance with sodium channel blocker mechanism of action (substance) true Inferred relationship Some
Lidocaine (substance) Is a Amide local anesthetic (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only hyaluronic acid and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing only lidocaine and phenylephrine in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing only lidocaine and tetracaine in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing only lidocaine in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing only lidocaine in nasal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing only lidocaine in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Lidocaine only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing only domiphen and lidocaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine and prilocaine only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing only lidocaine in gingival dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Lidocaine only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Hydrocortisone and lidocaine only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Cetylpyridinium and lidocaine only product in dental dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine and methylprednisolone only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine 50 microgram/mg cutaneous patch This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lidocaine (substance) Inferred relationship Some 1
Lidocaine 50 microgram/mg cutaneous patch The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lidocaine (substance) Inferred relationship Some 1
Adrenaline and lidocaine only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine and prilocaine only product in dental dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lidocaine (substance) Inferred relationship Some 2
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lidocaine (substance) Inferred relationship Some 2
Product containing lidocaine and prilocaine in dental dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Adrenaline- and lidocaine-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lidocaine (substance) Inferred relationship Some 2
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lidocaine (substance) Inferred relationship Some 2
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lidocaine (substance) Inferred relationship Some 2
Product containing precisely lidocaine 150 milligram/1 gram conventional release cutaneous spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lidocaine (substance) Inferred relationship Some 1
Product containing precisely lidocaine 150 milligram/1 gram conventional release cutaneous spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lidocaine (substance) Inferred relationship Some 1
Product containing lidocaine and nifedipine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing only lidocaine and nifedipine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing lidocaine and nifedipine in rectal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Lidocaine and nifedipine only product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing precisely lidocaine 15 milligram/1 gram and nifedipine 3 milligram/1 gram conventional release rectal cream (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lidocaine (substance) Inferred relationship Some 1
Product containing precisely lidocaine 15 milligram/1 gram and nifedipine 3 milligram/1 gram conventional release rectal cream (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lidocaine (substance) Inferred relationship Some 1
Product containing lidocaine and metronidazole and sucralfate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Product containing only lidocaine and metronidazole and sucralfate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Product containing benzoxonium and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Benzoxonium and lidocaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing benzoxonium and lidocaine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Benzoxonium and lidocaine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing glucose and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing glucose and lidocaine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Glucose and lidocaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Glucose and lidocaine only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing cetylpyridinium and chlorocresol and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Cetylpyridinium and chlorocresol and lidocaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Product containing cetylpyridinium and chlorocresol and lidocaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Cetylpyridinium and chlorocresol and lidocaine only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 3
Chlorhexidine and lidocaine only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing chlorhexidine and lidocaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine and naphazoline only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine- and naphazoline-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 2
Lidocaine- and naphazoline-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lidocaine (substance) Inferred relationship Some 1
Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lidocaine (substance) Inferred relationship Some 1
Product containing only amylmetacresol and dichlorobenzyl alcohol and lidocaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Amylmetacresol- and dichlorobenzyl alcohol- and lidocaine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing only amylmetacresol and dichlorobenzyl alcohol and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing amylmetacresol and dichlorobenzyl alcohol and lidocaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing only aminoacridine and lidocaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1
Product containing aminoacridine and lidocaine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine (substance) Inferred relationship Some 1

Start Previous Page 3 of 3


This concept is not in any reference sets

Back to Start